Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

W. A. Bleyer, P. F. Coccia, H. N. Sather, C. Level, J. Lukens, D. J. Niebrugge, S. Siegel, P. S. Littman, S. L. Leikin, D. R. Miller

Research output: Contribution to journalArticle

83 Scopus citations
Original languageEnglish (US)
Pages (from-to)317-325
Number of pages9
JournalJournal of Clinical Oncology
Volume1
Issue number5
DOIs
Publication statusPublished - Jan 1 1983

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bleyer, W. A., Coccia, P. F., Sather, H. N., Level, C., Lukens, J., Niebrugge, D. J., ... Miller, D. R. (1983). Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. Journal of Clinical Oncology, 1(5), 317-325. https://doi.org/10.1200/JCO.1983.1.5.317